Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc. financial statements

Black Diamond Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 70M10-K
Net incomeUSD 22.37M10-K
Cash and equivalentsUSD 20.99M10-Q
Total debtUSD 18.78MEODHD

Black Diamond Therapeutics, Inc. financials on 6ix · Black Diamond Therapeutics, Inc. on 6ix